Antibiotic resistance represents a major public health challenge, associated with a high mortality rate. While bacteriophages — viruses that kill bacteria — could be a solution for fighting antibiotic-resistant pathogens, various obstacles stand in the way of their clinical development. To overcome them, researchers have developed a model to better predict the efficacy of phage therapy and possibly develop more robust clinical trials.